selected scholarly activity
-
chapters
- Post Cardiac Surgery Rehabilitation. 687-696. 2021
- Aerobic Capacity and Aging 2012
- Heart Failure Management Programs. 163-180. 2004
- Heart Failure in the Frail Elderly. 139-162. 2004
- Prevention of Congestive Heart Failure and Treatment of Asymptomatic Left Ventricular Dysfunction. 643-658. 2002
- Factors Relating to 6 Minute Walk Performance in Heart Failure Patients. 315-322. 1995
- Neuromuscular Assessment of Heart Failure Patients. 433-442. 1995
-
conferences
- The Corcare Heart Function Optimization Protocol: A Structured Quality Improvement Intervention to Improve Goal Directed Targets for Patients With Reduced Ejection Fraction. Circulation. 2023
- Do Clinical Cardiopulmonary Exercise Tests Permit Exercise Threshold Identification In Patients Referred To Cardiac Rehabilitation?. Medicine & Science in Sports & Exercise. 141-142. 2023
- Flexible vs. fixed diuretic regimen in the management of advanced chronic heart failure: study protocol for a pilot randomized control trial. EUROPEAN JOURNAL OF HEART FAILURE. 167-168. 2023
- A Patient-Risk Based Health System Intervention for Acute Heart Failure Care: The Comparison of Outcomes and Access to Care for Heart Failure (COACH) Trial. Circulation. E571-E572. 2022
- Co-Designing Patient Care Pathways for Population Health Management. International Journal of Integrated Care. 137-137. 2022
- Anti-thymocyte globulin induction therapy usage is not associated with short and long-term survival differences in heart transplant patients. EUROPEAN JOURNAL OF HEART FAILURE. 280-280. 2019
- Hypertrophic cardiomyopathy unmasked after treatment of heart failure. EUROPEAN JOURNAL OF HEART FAILURE. 206-206. 2019
- Pulmonary hypertension and left atrial enlargement are associated with blunting of reduction in hospital resource utilization in patients enrolled in specialty heart failure clinic. EUROPEAN JOURNAL OF HEART FAILURE. 533-533. 2019
- The impact of ischemic time and procurement distance on long-term survival following heart transplantation in a tertiary care center: 30 years of experience. EUROPEAN JOURNAL OF HEART FAILURE. 282-282. 2019
- Correlation of Initial Echocardiographic Parameters and Emergency Room Admission Rates in Heart Failure Clinic Patients. The Journal of Heart and Lung Transplantation. S377-S377. 2019
- Heart Transplant Induction Therapy in Canada: A National Survey. The Journal of Heart and Lung Transplantation. S277-S277. 2019
- The "Hub and Spoke" Model of Heart Function Care Achieves Quality Index Markers. Circulation. 2018
- Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions. Value in Health. A605-A605. 2017
- Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada. Circulation. 2017
- Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada. Circulation. 2017
- The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial. Circulation. 2015
- A Prediction Model for Sudden Cardiac Death in Patients With Heart Failure and Preserved Ejection Fraction. EUROPEAN JOURNAL OF HEART FAILURE. 2014
- Which formula for estimating glomerular filtration rate is the better predictor of outcomes in heart failure with preserved ejection fraction? An analysis from the I-Preserve trial. European Heart Journal. 2-2. 2014
- Risk of Clinical Outcomes and Baseline Atrial Fibrillation: Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial. Circulation. 2013
- Why Are patients With Heart Failure and Preserved Ejection Fraction Hospitalized? Data From I-PRESERVE. Circulation. 2013
- Altered Executive Function in Older Heart Failure Patients at Hospital Discharge: New Data from the Montreal Cognitive Assessment Tool. Journal of Cardiac Failure. S83-S84. 2013
- MORBIDITY AND MORTALITY IN DIABETICS WITH HEART FAILURE AND A PRESERVED EJECTION FRACTION: RESULTS FROM THE I-PRESERVE TRIAL. Journal of the American College of Cardiology. E706-E706. 2013
- High Prevalence of Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge. Circulation. 2012
- 647 Evaluating Awareness and Knowledge of the Canadian Cardiovascular Society's Guidelines for the Diagnosis and Management of Heart Failure Among Residents in General Internal and Family Medicine: A Pilot Study. Canadian Journal of Cardiology. S343-S343. 2012
- 656 The Association Between Cognitive Function and Self-Care in Older Patients With Heart Failure. Canadian Journal of Cardiology. S347-S347. 2012
- 822 Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge and its Impact on Self-Care - Results of a Prospective Study. Canadian Journal of Cardiology. S415-S416. 2012
- N008 New Insight Into Predictors of Self-Care Confidence in Older Patients With Heart Failure. Canadian Journal of Cardiology. S422-S422. 2012
- Cognitive Function in Older Heart Failure Patients Is Similar to Older Patients Following Stroke. Journal of Cardiac Failure. S65-S65. 2012
- DEPRESSION AND NEUROHORMONAL MODULATION IN PATIENTS UNDERGOING TREATMENT FOR CONGESTIVE HEART FAILURE: RANDOMIZED EVALUATION OF STRATEGIES FOR LEFT VENTRICULAR DYSFUNCTION SUBSTUDY. Journal of the American College of Cardiology. E899-E899. 2012
- Predictors of early ambulation after acute myocardial infarction. European Journal of Cardiovascular Nursing. S40-S40. 2012
- Does the 6 Minute Walk Test Provide Useful Prognostic Information in Systolic Heart Failure Patients?. Circulation. 2011
- Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients with Heart Failure and Preserved Ejection Fraction: The I-PRESERVE Trial. Circulation. 2011
- Canadian Heart Failure Patient and Caregiver Emotions. Journal of Cardiac Failure. S80-S80. 2011
- PREDICTORS OF UNCERTAINTY IN CAREGIVERS OF PATIENTS WITH HEART FAILURE - A LONGITUDINAL STUDY. Canadian Journal of Cardiology. 151D-152D. 2010
- THE CANADIAN CARDIOVASCULAR SOCIETY GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF HEART FAILURE: RESULTS OF A 5-YEAR CLOSED LOOP IMPLEMENTATION PROGRAM. Canadian Journal of Cardiology. 124D-124D. 2010
- The Dutch Objective Burden Inventory – Validity and Reliability Testing in Canada. Journal of Cardiac Failure. S114-S114. 2010
- Obesity and Its Relationship to Adverse Cardiovascular Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction in the I-PRESERVE Trial. Circulation. S757-S758. 2009
- Quality of Life Questionnaire Responsiveness and Lack of Relationship to Functional Capacity: Findings From the Exercise Rehabilitation Trial (EXERT). Circulation. S511-S511. 2009
- The Relation of Quality of Life Score to Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial (I-PRESERVE). Circulation. S749-S749. 2009
- Combined therapy with angiotensin receptor antagonists and ACE inhibitors versus standard therapy in patients with heart failure: a meta-analysis of randomized controlled trials. European Heart Journal. 165-165. 2009
- Predictors of outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in heart failure with preserved ejection fraction trial (I-PRESERVE). European Heart Journal. 865-865. 2009
- Relationship Between NTproBNP and Exercise Capacity in Chronic Heart Failure: Baseline Data from the HF-ACTION Study. Journal of the American College of Cardiology. A189-A189. 2009
- Prescribing Barriers to Heart Failure Management in Primary Care. Circulation. S1028-S1028. 2008
- Health related quality of life in the Irbesartan in heart failure with preserved systolic function trial (I-PRESERVE). European Heart Journal. 156-156. 2008
- Health Related Quality of Life in I-PRESERVE Trial. Journal of Cardiac Failure. S73-S73. 2008
- Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF PEF). Findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE). Circulation. 551-551. 2007
- Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction findings from the irbesartan in heart failure with preserved systolic function trial (I-PRESERVE). Circulation. 706-707. 2007
- Diabetes mellitus is associated with increased risk of fatal and non-fatal cardiovascular events in heart failure patients with preserved ejection fraction - Findings from the Irbesartan in heart failure with preserved systolic function trial. Circulation. 826-826. 2007
- Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve). Circulation. 552-552. 2007
- Congestive heart failure assessment and management in primary care (CHAMP-C). Canadian Journal of Cardiology. 298C-298C. 2007
- Baseline plasma NT-proBNP concentrations in relation to clinical characteristics: results from the irbesartan in heart failure with preserved systolic function trial. European Heart Journal. 145-145. 2007
- NT-pro BNP and diastolic dysfunction by echocardiography predicts cardiovascular outcomes in patients with heart failure and preserved systolic function. European Heart Journal. 271-271. 2007
- 156 NT-proBNP predicts cardiovascular outcomes in patients with heart failure and preserved ejection fraction. European Journal of Heart Failure, Supplement. 40-40. 2007
- 59 BNP predicts echocardiographic severity of diastolic dysfunction in heart failure. European Journal of Heart Failure, Supplement. 10-10. 2007
- N-terminal pro BNP is associated with cardiac structure and function in elderly patients with heart failure and preserved systolic function; the iPRESERVE study. Journal of the American College of Cardiology. 54A-54A. 2007
- Performance characteristics of BNP and NT-proBNP in the diagnosis of heart failure: A systematic review of the evidence. Clinical Biochemistry. 1101-1101. 2006
- Baseline plasma NT-proBNP concentrations in relation to clinical characteristics: Results from the irbesartan in heart failure with preserved systolic function trial. Circulation. 721-721. 2006
- Cardiac structural changes and diastolic function in heart failure with preserved ejection fraction - Importance of left atrial volume: the iPRESERVE study. Circulation. 816-816. 2006
- The Baseline Characteristics of Patients Enrolled in the Irbesartan in Heart Failure with Preserved Systolic Function Trial Are Similar to Those in the Community but Differ from CHARM-Preserved. Journal of Cardiac Failure. S77-S77. 2006
- Diastolic dysfunction in heart failure with preserved systolic - Function need for objective evidence. Results from the CHARM echocardiographic substudy - CHARMES. Circulation. U469-U469. 2005
- Diastolic dysfunction in heart failure with preserved systolic function - need for objective evidence. Results from the CHARM Echocardiographic Substudy - CHARMES. European Heart Journal. 14-14. 2005
- Left ventricular mass is lower with candesartan compared to placebo in patients with heart failure and preserved systolic function. Results from the CHARM echocardiographic substudy - CHARMES. Journal of Cardiac Failure. S152-S152. 2005
- Haemodynamic and neurohormonal effects ofAT-receptor Blockers. European Heart Journal, Supplement. H49-H54. 2004
- Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. Circulation. 560-560. 2004
- Impact of candesartan in preventing myocardial infarction: Results of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme. Circulation. 514-514. 2004
- Unrecognized cognitive impairment is common in heart failure outpatients. Circulation. 640-640. 2004
- Response to cardiac rehabilitation after coronary artery bypass graft surgery in patients with and without type 2 diabetes mellitus. European Heart Journal. 507-508. 2004
- 1049-114 Increasing atrial natriuretic peptide over time independently predicts higher short-term mortality and morbidity in heart failure. Journal of the American College of Cardiology. A172-A172. 2004
- 1087-103 Plasma metalloproteinase levels are correlated with natriuretic peptide and endothelin-1 levels in patients with heart failure. Journal of the American College of Cardiology. A188-A188. 2004
- Plasma metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in heart failure patients. Circulation. 345-345. 2003
- Prevalence of overweight and obesity in a Canadian cardiac rehabilitation setting. Obesity. A128-A128. 2003
- Neurohumoral changes as markers of progressive left ventricular remodeling in systolic heart failure: Results of the neurohumoral substudy of the randomized evaluation of strategies for left ventricular dysfunction (RESOLVD). Journal of the American College of Cardiology. 141-141. 2003
- Benefits of Exercise in Patients with Congestive Heart Failure. FRONTIERS IN CARDIOVASCULAR HEALTH. 507-517. 2003
- Natriuretic peptides predict left ventricular remodeling in response to metoprolol CR in patients with congestive heart failure: the RESOLVD phase II neurohumoral substudy. Journal of the American College of Cardiology. 139-139. 2002
- Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials. Circulation. 596-596. 2001
- Predictive value of natriuretic peptides and endothelin-1 for LV remodelling in response to candesartan and enalapril: the RESOLVD neurohumoral ancillary study. European Heart Journal. 40-40. 2001
- Predictive value of natriuretic peptides and endothelin-1 for LV remodeling in response to candesartan and enalapril: The RESOLVD neurohumoral ancillary study. Circulation. 27-27. 2000
- Metoprolol in chronic heart failure: Natriuretic peptides involved in mechanism of action?. Circulation. 783-783. 1999
- Exercise activates the thrombotic/fibrinolytic system in patients with coronary artery disease. Circulation. 765-765. 1998
- Single versus double versus triple therapy to block neurohormonal effects on ventricular remodeling. Circulation. 780-780. 1998
- Increased Insulin and Glucose Levels in Heart Failure (HF). Journal of the American College of Cardiology. 249A-249A. 1998
- Randomized Controlled Trial of Exercise Training in Patients With Congestive Heart Failure (EXERT). Journal of the American College of Cardiology. 508A-509A. 1998
- Patterns of autonomic dysregulation in congestive heart failure: Relationship with LV function and neurohumoral activation. Circulation. 1909-1909. 1996
- COMPARATIVE EFFECTS OF LOSARTAN AND ENALAPRIL ON EXERCISE CAPACITY AND CLINICAL STATUS IN PATIENTS WITH HEART-FAILURE. Circulation. 602-602. 1994
- EFFECT OF GLYCOGEN DEPLETION AND LOADING ON SKELETAL-MUSCLE PYRUVATE-DEHYDROGENASE ACTIVATION IN HUMANS DURING EXERCISE. The FASEB Journal. A1541-A1541. 1992
- EFFECTS OF ACETAZOLAMIDE (ACZ) ON VENTILATION DURING THE TRANSITION BETWEEN 2 LEVELS OF STEADY-STATE EXERCISE. The FASEB Journal. 1004-1004. 1986
-
journal articles
- A Protocol to Establish Exercise Intensity Domains for Aerobic Exercise Training in Coronary Artery Disease.. Medicine & Science in Sports & Exercise. 57:1593-1602. 2025
- Prescription Drug Coverage of Guideline-Directed Medical Therapy for People Living with Heart Failure with Reduced Ejection Fraction in Canada. CJC OPEN. 2025
- Economic Burden of Heart Failure Hospitalizations in Canada: A Population-based Study.. CJC OPEN. 7:279-286. 2025
- The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Outpatients with Heart Failure.. CJC OPEN. 7:1-9. 2025
- “Is This Thing On?: Measuring Technology Self-Efficacy Influence on Cardiac Rehabilitation Patients’ Adoption of a Virtual Care Platform. CJC OPEN. 2025
- Aging with Heart Failure: Muscle Matters.. Canadian Journal of Cardiology. 40:2552-2554. 2024
- Virtual care during COVID-19: The perspectives of older adults and their healthcare providers in a cardiac rehabilitation setting. Canadian Journal on Aging. 43:1-8. 2024
- A standardized approach to evaluate effectiveness of aerobic exercise training interventions in cardiovascular disease at the individual level. International Journal of Cardiology. 412:132335-132335. 2024
- ASSOCIATIONS OF BIOLOGICAL SEX WITH CARDIAC REHABILITATION UTILIZATION AND PROGRAM OUTCOMES BEFORE VS DURING THE COVID-19 PANDEMIC. Canadian Journal of Cardiology. 40:s132-s133. 2024
- An Innovative Patient-Centred Approach to Heart Failure Management: The Best Care Heart Failure Integrated Disease-Management Program. CJC OPEN. 6:989-1000. 2024
- An Innovative Patient-Centred Approach to Heart Failure Management: The Best Care Heart Failure Integrated Disease-Management Program. CJC OPEN. 6:989-1000. 2024
- Yes, Frailty Matters: Time for Action. Canadian Journal of Cardiology. 40:685-687. 2024
- Are We Implanting Too Many Primary-Prevention Implantable Cardioverter-Defibrillators?. Canadian Journal of Cardiology. 40:1592-1595. 2024
- Quantifying Improvement in V˙o 2peak and Exercise Thresholds in Cardiovascular Disease Using Reliable Change Indices. Journal of Cardiopulmonary Rehabilitation and Prevention. 44:121-130. 2024
- A COMPREHENSIVE TRANSITIONAL CARE PROGRAM FOR HEART FAILURE PATIENTS REDUCES HOSPITAL READMISSION. Canadian Journal of Diabetes. 47:s34-s35. 2023
- Do Clinical Exercise Tests Permit Exercise Threshold Identification in Patients Referred to Cardiac Rehabilitation?. Canadian Journal of Cardiology. 39:1701-1711. 2023
- THE CANADIAN HEART FAILURE (CAN-HF) REGISTRY: A CANADIAN MULTI-CENTRE, RETROSPECTIVE STUDY OF OUTPATIENTS WITH HEART FAILURE. Canadian Journal of Diabetes. 47:s197. 2023
- A COMPREHENSIVE TRANSITIONAL CARE PROGRAM FOR HEART FAILURE PATIENTS REDUCES HOSPITAL READMISSION. Canadian Journal of Cardiology. 39:s57. 2023
- Access to Heart Failure Services in Canada: Findings of the Heart and Stroke National Heart Failure Resources and Services Inventory. Canadian Journal of Cardiology. 39:1469-1479. 2023
- THE CANADIAN HEART FAILURE (CAN-HF) REGISTRY: A CANADIAN MULTI-CENTRE, RETROSPECTIVE STUDY OF OUTPATIENTS WITH HEART FAILURE. Canadian Journal of Cardiology. 39:s237. 2023
- Do Clinical Cardiopulmonary Exercise Tests Permit Exercise Threshold Identification In Patients Referred To Cardiac Rehabilitation?. Medicine & Science in Sports & Exercise. 55:141-142. 2023
- Exploring the Comparative Roles of a Canadian Primary Care and Tertiary Care Heart Function Clinic. Canadian Journal of General Internal Medicine. 18:49-56. 2023
- Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization. JACC: Heart Failure. 11:596-606. 2023
- Trial of an Intervention to Improve Acute Heart Failure Outcomes. New England Journal of Medicine. 388:22-32. 2023
- Transitional Care from Hospital to Cardiac Rehabilitation During COVID-19: The Perspectives of Older Adults and Their Healthcare Providers. Journal of Patient Experience. 10:23743735231213757. 2023
- THE STATE OF HEART FAILURE SERVICES IN CANADA: FINDINGS OF THE HEART & STROKE NATIONAL HEART FAILURE RESOURCES AND SERVICES INVENTORY. Canadian Journal of Cardiology. 38:S188-S189. 2022
- The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies. CJC OPEN. 4:667-675. 2022
- The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Inpatients With Heart Failure. CJC OPEN. 4:636-643. 2022
- Primary care-based integrated disease management for heart failure: a study protocol for a cluster randomised controlled trial. BMJ Open. 12:e058608-e058608. 2022
- Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. The Lancet. 399:1391-1400. 2022
- Prévention et traitement de l’hyperkaliémie chez les patients sous inhibiteurs du système rénine–angiotensine–aldostérone. CANADIAN MEDICAL ASSOCIATION JOURNAL. 194:E391-E397. 2022
- Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E1836-E1841. 2021
- Confronting complexity and supporting transformation through health systems mapping: a case study. BMC Health Services Research. 21:1146. 2021
- Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study. CJC OPEN. 3:1463-1470. 2021
- Assessments of Heart Failure and Frailty-Related Health Instability Provide Complementary and Useful Information for Home-Care Planning and Prognosis. Canadian Journal of Cardiology. 37:1767-1774. 2021
- Long-Term Enrollment in Cardiac Rehabilitation Benefits of Cardiorespiratory Fitness and Skeletal Muscle Strength in Females with Cardiovascular Disease. Women's Health Reports. 2:543-549. 2021
- Tissue Sodium Storage in Patients With Heart Failure: A New Therapeutic Target?. Circulation. Cardiovascular Imaging. 14:e012910. 2021
- IMPACT OF DOOR-TO-FUROSEMIDE TIME ON CLINICAL OUTCOMES IN PATIENTS WITH ACUTE HEART FAILURE. Canadian Journal of Cardiology. 37:S58-S59. 2021
- Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction. Clinical Research in Cardiology. 110:1234-1248. 2021
-
Contemporary use of
guideline‐based higher potencyP2Y12 receptor inhibitor therapy in patients withmoderate‐to‐high risknon‐ST‐segment elevation myocardial infarction: Results from the CanadianACS reflectiveII cross‐sectional study. Clinical Cardiology. 44:839-847. 2021 - Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure. CJC OPEN. 3:609-618. 2021
- CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. Canadian Journal of Cardiology. 37:531-546. 2021
- Sex, Depression, and More in Cardiac Rehabilitation. Canadian Journal of Cardiology. 37:357-358. 2021
- Long-term enrollment in cardiac rehabilitation benefits cardiorespiratory fitness and skeletal muscle strength in women with cardiovascular disease. Canadian Journal of Cardiology. 37:e11-e11. 2021
- Covariate adjusted reanalysis of the I-Preserve trial. Clinical Research in Cardiology. 109:1358-1365. 2020
- Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada. CJC OPEN. 2:321-327. 2020
- Effect of a formalised discharge process which includes electronic delivery of prescriptions to pharmacies on the incidence of delayed prescription retrieval. BMJ quality improvement reports. 9:e000849-e000849. 2020
- The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey. CJC OPEN. 2:151-160. 2020
- Erratum. Journal of the American Medical Directors Association. 21:568-568. 2020
- CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. Canadian Journal of Cardiology. 36:159-169. 2020
- Therapies for Advanced Heart Failure Patients Ineligible for Heart Transplantation: Beyond Pharmacotherapy. Canadian Journal of Cardiology. 36:234-243. 2020
- The Role of Physicians in the Era of Big Data. Canadian Journal of Cardiology. 36:19-21. 2020
- DIVERT-Collaboration Action Research and Evaluation (CARE) Trial Protocol: a multiprovincial pragmatic cluster randomised trial of cardiorespiratory management in home care. BMJ Open. 9:e030301-e030301. 2019
- Sex-Related Differences in Heart Failure With Preserved Ejection Fraction. Circulation. Heart Failure. 12:e006539. 2019
- A SYSTEMS APPROACH TO INTEGRATING HEART FAILURE CARE: A ‘HOW TO’ ROAD MAP BASED ON LIVED EXPERIENCE. Canadian Journal of Cardiology. 35:S25-S26. 2019
- ASSESSING THE QUALITY OF CARE FOR PATIENTS HOSPITALIZED WITH ATRIAL FIBRILLATION/ATRIAL FLUTTER IN CANADA. Canadian Journal of Cardiology. 35:S18-S19. 2019
- CONNECTING CARE TO HOME FOR HEART FAILURE PATIENTS: AN EFFECTIVE STRATEGY TO REDUCE HOSPITAL READMISSION RATES. Canadian Journal of Cardiology. 35:S201-S202. 2019
- Long-term Enrollment in Cardiac Rehabilitation Benefits Cardiorespiratory Fitness and Skeletal Muscle Strength in Men With Cardiovascular Disease. Canadian Journal of Cardiology. 35:1359-1365. 2019
- OUTCOMES OF AN ATRIAL FIBRILLATION PATIENT NAVIGATION DEMONSTRATION PROJECT. Canadian Journal of Cardiology. 35:S62-S63. 2019
- THE EFFECT OF A FORMALIZED DISCHARGE PROCESS WHICH INCLUDES ELECTRONIC DELIVERY OF PRESCRIPTIONS TO PHARMACIES ON THE INCIDENCE OF DELAYED PRESCRIPTION RETRIEVAL AMONG PATIENTS DISCHARGED FROM CARDIAC INPATIENT CARE. Canadian Journal of Cardiology. 35:S96-S96. 2019
- Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 74:601-612. 2019
- Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE. 21:974-984. 2019
- An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter. CJC OPEN. 1:198-205. 2019
- Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart Failure. 7:418-427. 2019
- Predicting Future Health Transitions Among Newly Admitted Nursing Home Residents With Heart Failure. Journal of the American Medical Directors Association. 20:438-443. 2019
- Can a complex adaptive systems perspective support the resiliency of the heart failure patient – informal caregiver dyad?. Current opinion in supportive and palliative care. 13:9-13. 2019
- Enhancing Knowledge and InterProfessional care for Heart Failure (EKWIP-HF) in long-term care: a pilot study. Pilot and Feasibility Studies. 4:9. 2018
- Impact of exercise‐based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta‐analysis of randomised trials. EUROPEAN JOURNAL OF HEART FAILURE. 20:1735-1743. 2018
- CONTEMPORARY ANTIPLATELET THERAPY IN MODERATE TO HIGH-RISK PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN ACS REFLECTIVE II STUDY. Canadian Journal of Cardiology. 34:S11-S12. 2018
- LONG-TERM MEMBERSHIP IN CARDIAC REHABILITATION PRESERVES CARDIORESPIRATORY FITNESS AND MUSCLE STRENGTH IN MEN WITH CARDIOVASCULAR DISEASE: A RETROSPECTIVE REVIEW. Canadian Journal of Cardiology. 34:S39-S40. 2018
- Heart Failure Management in Nursing Homes: A Scoping Literature Review. Canadian Journal of Cardiology. 34:871-880. 2018
- The Spoke-Hub-and-Node Model of Integrated Heart Failure Care. Canadian Journal of Cardiology. 34:863-870. 2018
- “NEW” Prehabilitation: A 3-Way Approach to Improve Postoperative Survival and Health-Related Quality of Life in Cardiac Surgery Patients. Canadian Journal of Cardiology. 34:839-849. 2018
- IVC Assessment by Ultrasound in Acute and Ambulatory Heart Failure Patients Predictive of Mortality and Readmissions: A Systematic Review. The Journal of Heart and Lung Transplantation. 37:S323-S323. 2018
- Abstract P171: The “Hub and Spoke” Model of Heart Function Care Achieves Quality Index Markers. Circulation. 137. 2018
- Individualizing the care of older heart failure patients. Current Opinion in Cardiology. 33:208-216. 2018
- Management of Non-ST-Elevation Myocardial Infarction in Elderly Patients: Time to Consider Frailty and Quality of Life. Canadian Journal of Cardiology. 34:241-243. 2018
- Pulling together and pulling apart: influences of convergence and divergence on distributed healthcare teams. Advances in Health Sciences Education. 22:1085-1099. 2017
- 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Canadian Journal of Cardiology. 33:1342-1433. 2017
- DEVELOPMENT OF KEY HEART FAILURE CLINICAL INDICATORS FOR A COMMUNITY ELECTRONIC MEDICAL RECORD. Canadian Journal of Cardiology. 33:S220-S220. 2017
- HEART FAILURE GUIDELINES APPLIED IN PRACTICE (HF-GAP) TOOLKIT REVISION 2016. Canadian Journal of Cardiology. 33:S219-S219. 2017
- OPTIMAL USAGE OF SACUBITRIL/VALSARTAN FOR HEART FAILURE TREATMENT IN CANADA POTENTIALLY REDUCES HOSPITALIZATIONS AND EARLY DISCHARGE RE-ADMISSIONS. Canadian Journal of Cardiology. 33:S161-S161. 2017
- Implementation of an interprofessional communication and collaboration intervention to improve care capacity for heart failure management in long-term care. Journal of Interprofessional Care. 31:583-592. 2017
- Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. The Lancet Global Health. 5:e665-e672. 2017
- IMPROVING THE KNOWLEDGE AND INTERPROFESSIONAL CARE FOR HEART FAILURE IN NURSING HOMES: A PILOT STUDY. Innovation in Aging. 1:782-783. 2017
- THE DIVERT-CARE CATALYST TRIAL: TARGETED CHRONIC-DISEASE MANAGEMENT FOR HOME CARE CLIENTS. Innovation in Aging. 1:322-323. 2017
- ‘Who is on your health‐care team?’ Asking individuals with heart failure about care team membership and roles. Health Expectations. 20:198-210. 2017
- Abstract P171: Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada. Circulation. 135. 2017
- Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. European Heart Journal. 38:ehw509-ehw509. 2017
- The role of unregulated care providers in managing heart failure patients in long‐term care facilities. Journal of Clinical Nursing (JCN). 26:849-861. 2017
- Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction. Circulation. 135:724-735. 2017
- Evaluating the Performance of a Single-Item, Global, Estimate of Missed Nursing Care. Journal of Nursing Measurement. 25:121-141. 2017
- Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction. Journal of Cardiac Failure. 23:20-28. 2017
- Managing Heart Failure in Long-Term Care: Recommendations from an Interprofessional Stakeholder Consultation. Canadian Journal on Aging. 35:447-464. 2016
- The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation. Canadian Journal of Cardiology. 32:1566-1569. 2016
- Canadian Cardiovascular Society Quality Indicators for Heart Failure. Canadian Journal of Cardiology. 32:1038.e5-1038.e9. 2016
- Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I‐PRESERVE) trial. EUROPEAN JOURNAL OF HEART FAILURE. 18:1021-1031. 2016
- Technology-Enabled Remote Monitoring and Self-Management — Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol. JMIR Research Protocols. 5:e149-e149. 2016
- Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. New England Journal of Medicine. 374:2009-2020. 2016
- Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. New England Journal of Medicine. 374:2032-2043. 2016
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. New England Journal of Medicine. 374:2021-2031. 2016
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE). Diabetes Care. 39:709-716. 2016
- The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice. Canadian Journal of Cardiology. 32:296-310. 2016
- Corrigendum to “Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)” (Am Heart J. 2015;170[4]:627-634). American Heart Journal. 172:201-201. 2016
- Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study. International Journal of Cardiology. 204:133-141. 2016
- Importance of early cardiac rehabilitation on changes in exercise capacity: a retrospective pilot study. Applied Physiology, Nutrition and Metabolism. 40:1314-1317. 2015
- Abstract 14299: The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial. Circulation. 132. 2015
- Effects of resistance training combined with moderate-intensity endurance or low-volume high-intensity interval exercise on cardiovascular risk factors in patients with coronary artery disease. Journal of Science and Medicine in Sport. 18:637-642. 2015
- The CREATE Method for Expressing Continuous Outcome Data in Absolute Terms for Use in Patient Treatment Decision Aids. Medical decision making. 35:959-966. 2015
- AN INVESTIGATION OF A NON-INVASIVE JUGULAR VENOUS PRESSURE POINT OF CARE DEVICE TO DIAGNOSE AND ASSESS HEART FAILURE IN LONG TERM AND PRIMARY CARE: A MIXED METHOD APPROACH. Canadian Journal of Cardiology. 31:S127-S127. 2015
- CORE HEART TEAMS: IMPROVING INTERPROFESSIONAL COMMUNICATION FOR HEART FAILURE MANAGEMENT IN LONG-TERM CARE. Canadian Journal of Cardiology. 31:S274-S274. 2015
- ENVIRONMENTAL SCAN OF SELF-IDENTIFIED HEART FAILURE CLINICS IN ONTARIO. Canadian Journal of Cardiology. 31:S127-S127. 2015
- Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF). American Heart Journal. 170:627-634.e1. 2015
- INTERPROFESSIONAL CARE PROCESSES TO MANAGE RESIDENTS WITH HEART FAILURE IN LONG-TERM CARE. Canadian Journal of Cardiology. 31:S128-S128. 2015
- THE ROLE OF REGISTERED NURSES AND NURSE PRACTITIONER’S WITHIN HEART FAILURE CLINIC TEAMS IN ONTARIO. Canadian Journal of Cardiology. 31:S323-S323. 2015
- Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. EUROPEAN JOURNAL OF HEART FAILURE. 17:925-935. 2015
- Changes in N‐terminal pro‐B‐type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I‐Preserve study. EUROPEAN JOURNAL OF HEART FAILURE. 17:809-817. 2015
- Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina. Circulation. Heart Failure. 8:717-724. 2015
- Exercise Capacity and Aging. American Journal of Lifestyle Medicine. 9:252-265. 2015
- Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro–B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC: Heart Failure. 3:478-486. 2015
- The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 3:429-441. 2015
- Mobilization Patterns of Patients After an Acute Myocardial Infarction. Clinical Nursing Research. 24:139-155. 2015
- Evidence based application of BNP/NT-proBNP testing in heart failure. Clinical Biochemistry. 48:236-246. 2015
- Physicians' perceptions of capacity building for managing chronic disease in seniors using integrated interprofessional care models.. Canadian Family Physician. 61:e148-e157. 2015
- Cerebral Hypoperfusion Is Exaggerated With an Upright Posture in Heart Failure. JACC: Heart Failure. 3:168-175. 2015
- Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE. 17:169-176. 2015
- International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction. Circulation. 131:43-53. 2015
- The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications. Canadian Journal of Cardiology. 31:3-16. 2015
- Impact of self-management interventions on stable angina symptoms and health-related quality of life: a meta-analysis. BMC Cardiovascular Disorders. 14:14. 2014
- Risk of emergency department use among community-dwelling older adults: a review of risk factors and screening methods. ??????????? ????????. 11:763-776. 2014
- A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE. 16:1175-1182. 2014
- History of Atrial Fibrillation as a Risk Factor in Patients With Heart Failure and Preserved Ejection Fraction. Circulation. Heart Failure. 7:960-966. 2014
- The journey of the frail older adult with heart failure: implications for management and health care systems. Reviews in Clinical Gerontology. 24:269-289. 2014
- TOWARDS GUIDELINE INFORMED LONG TERM CARE FOR RESIDENTS WITH HEART FAILURE: INFLUENCES ON THE NURSE’S ROLE. Canadian Journal of Cardiology. 30:S360-S360. 2014
- Managing Heart Failure in the Long-Term Care Setting. Nursing Research. 63:357-365. 2014
- Perspectives of Primary-Care Providers on Heart Failure in Long-Term Care Homes. Canadian Journal on Aging. 33:320-335. 2014
- Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment. Journal of the American College of Cardiology. 64:1106-1113. 2014
- A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods. Heart Failure Reviews. 19:413-419. 2014
- B-type natriuretic peptide-guided therapy: a systematic review. Heart Failure Reviews. 19:553-564. 2014
- BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Failure Reviews. 19:453-470. 2014
- BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Failure Reviews. 19:471-505. 2014
- Erratum to: Conflict of interest declaration. Heart Failure Reviews. 19:565-565. 2014
- Incremental predictive value of natriuretic peptides for prognosis in the chronic stable heart failure population: a systematic review. Heart Failure Reviews. 19:521-540. 2014
- Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review. Heart Failure Reviews. 19:507-519. 2014
- Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review. Heart Failure Reviews. 19:439-451. 2014
- Prediction of clinical outcomes using B-type natriuretic peptides in the general population: a systematic review. Heart Failure Reviews. 19:541-551. 2014
- Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence. Heart Failure Reviews. 19:421-438. 2014
- Management Considerations in the Care of Elderly Heart Failure Patients in long-term Care Facilities. Future Cardiology. 10:563-577. 2014
- Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I‐Preserve). EUROPEAN JOURNAL OF HEART FAILURE. 16:778-787. 2014
- Cognitive function and self-care management in older patients with heart failure. European Journal of Cardiovascular Nursing. 13:277-284. 2014
- The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization. Canadian Journal of Cardiology. 30:249-263. 2014
- Brachial Artery Endothelial Responses during Early Recovery from an Exercise Bout in Patients with Coronary Artery Disease. BioMed Research International. 2014:1-8. 2014
- Development of a patient decision aid for people with refractory angina: protocol for a three-phase pilot study. Health and Quality of Life Outcomes. 12:93-93. 2014
- Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines. Canadian Journal of Cardiology. 29:1535-1552. 2013
- Home Administered Lasix Therapy in Patients With Heart Failure and Chronic Congestion (HALT). Canadian Journal of Cardiology. 29:S387-S387. 2013
- Self-Care in Heart Failure Index- Do Scores Change Over Time?. Canadian Journal of Cardiology. 29:S403-S404. 2013
- Living and dying with heart failure in long-term care: experiences of residents and their family members. International Journal of Palliative Nursing. 19:375-382. 2013
- Low-Volume, High-Intensity Interval Training in Patients with CAD. Medicine & Science in Sports & Exercise. 45:1436-1442. 2013
- Heart Failure–Related Mortality and Hospitalization in the Year Following Admission to a Long-Term Care Facility: The Geriatric Outcomes and Longitudinal Decline in Heart Failure (GOLD-HF) Study. Journal of Cardiac Failure. 19:468-477. 2013
- Heart rate recovery and heart rate variability are unchanged in patients with coronary artery disease following 12 weeks of high-intensity interval and moderate-intensity endurance exercise training. Applied Physiology, Nutrition and Metabolism. 38:644-650. 2013
- The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure. Canadian Journal of Cardiology. 29:168-181. 2013
- The Measurement of Uncertainty in Caregivers of Patients With Heart Failure. Journal of Nursing Measurement. 21:23-42. 2013
- The Value of Admission Clinical Data for Diagnosing Heart Failure in Long-term Care. Canadian Geriatrics Journal. 16:147-155. 2013
- 6-Min Walk Test Provides Prognostic Utility Comparable to Cardiopulmonary Exercise Testing in Ambulatory Outpatients With Systolic Heart Failure. Journal of the American College of Cardiology. 60:2653-2661. 2012
- Abstract 18993: High Prevalence of Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge. Circulation. 126. 2012
- Flow-Mediated Dilation Is Acutely Improved after High-Intensity Interval Exercise. Medicine & Science in Sports & Exercise. 44:2057-2064. 2012
- Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction. Circulation. Heart Failure. 5:571-578. 2012
- Response to Letters Regarding Article, “Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction”. Circulation. 126:E64-E65. 2012
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia. New England Journal of Medicine. 367:319-328. 2012
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia. New England Journal of Medicine. 367:309-318. 2012
- The older patient with heart failure: high risk for frailty and cognitive impairment. Expert Review of Cardiovascular Therapy. 10:779-795. 2012
- Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial. Circulation. Heart Failure. 5:217-225. 2012
- Predicting heart failure mortality in frail seniors: Comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0. International Journal of Cardiology. 155:75-80. 2012
- Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction. Circulation. 124:2491-2501. 2011
- The Dutch Objective Burden Inventory: Validity and Reliability in a Canadian Population of Caregivers for People with Heart Failure. European Journal of Cardiovascular Nursing. 10:234-240. 2011
- What are the effects of care rationing?. Nursing New Zealand. 17:34. 2011
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction. Circulation. Heart Failure. 4:569-577. 2011
- Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction. Circulation. Heart Failure. 4:561-568. 2011
- Heart failure.. American Family Physician. 2011:0204. 2011
- Six-year follow-up of a randomised controlled trial examining hospital versus home-based exercise training after coronary artery bypass graft surgery. Heart. 97:1169-1174. 2011
- Clinical, Demographic and Functional Characteristics Associated with Pharmacotherapy for Heart Failure in Older Home Care Clients. Drugs and Aging. 28:561-573. 2011
- The 2011 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Sleep Apnea, Renal Dysfunction, Mechanical Circulatory Support, and Palliative Care. Canadian Journal of Cardiology. 27:319-338. 2011
- Screening for Cognitive Deficits Using the Montreal Cognitive Assessment Tool in Outpatients ≥65 Years of Age With Heart Failure. American Journal of Cardiology. 107:1203-1207. 2011
- Clinical, Demographic and Functional Characteristics Associated with Pharmacotherapy for Heart Failure in Older Home Care Clients. Drugs and Aging. 28:561-573. 2011
- Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction. Circulation. Heart Failure. 4:27-35. 2011
- Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?. The BMJ. 341:c4202-c4202. 2010
- Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors. BMJ Evidence-Based Medicine. 15:51-52. 2010
- Hypertension as an Underlying Factor in Heart Failure With Preserved Ejection Fraction. Journal of Clinical Hypertension. 12:277-283. 2010
- Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure. PLoS ONE. 5:e9946-e9946. 2010
- The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Canadian Journal of Cardiology. 26:185-202. 2010
- Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction. Circulation. 121:1393-1405. 2010
- HEART FAILURE WITH PRESERVED EJECTION FRACTION: MORTALITY RISK POST FIRST HOSPITALIZATION - DATA FROM I-PRESERVE. Journal of the American College of Cardiology. 55:A141.E1321-A141.E1321. 2010
- Heart failure.. American Family Physician. 2010:0204. 2010
- Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial. Journal of Cardiac Failure. 16:128-134. 2010
- N-terminal pro–brain natriuretic peptide and exercise capacity in chronic heart failure: Data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. American Heart Journal. 158:S37-S44. 2009
- Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. American Heart Journal. 158:S72-S77. 2009
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure. Journal of the American Medical Association (JAMA). 301:1439-1439. 2009
- Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker. Therapeutic Advances in Cardiovascular Disease. 3:113-121. 2009
- FP4 Screening for Cognitive Deficits Using the Montreal Cognitive Assessment tool in Older Patients Attending a Heart Function Clinic. European Journal of Cardiovascular Nursing. 8:S13-S13. 2009
- FP7 The Dutch Objective Burden Inventory: Validity and Realiability in a Canadian Population of Caregivers for People with Heart Failure. European Journal of Cardiovascular Nursing. 8:S14-S14. 2009
- Diagnosis and management of heart failure with preserved ejection fraction in older adults. Geriatrics and Aging. 12:93-96. 2009
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Canadian Journal of Cardiology. 25:85-105. 2009
- The CHARM program: the effects of candesartan for the management of patients with chronic heart failure. Expert Review of Cardiovascular Therapy. 7:9-16. 2009
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. New England Journal of Medicine. 359:2456-2467. 2008
- Cardiovascular Aging and Exercise in Healthy Older Adults. Clinical Journal of Sport Medicine. 18:479-485. 2008
- Reproducibility of Peak Oxygen Uptake and Other Cardiopulmonary Exercise Testing Parameters in Patients With Heart Failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). American Journal of Cardiology. 102:712-717. 2008
- Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. American Journal of Cardiology. 102:733-737. 2008
- Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF-PEF). Findings from the I-PRESERVE trial. European Journal of Heart Failure, Supplement. 7:86-86. 2008
- Atrial fibrillation is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. European Journal of Heart Failure, Supplement. 7:161-161. 2008
- Diabetes is associated with increased risk of CV events in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial. European Journal of Heart Failure, Supplement. 7:2-2. 2008
- Predictors of outcome in heart failure with preserved ejection fraction: one year findings rom the Irbesartan in Heart Failure With Preserved Systolic Function Trial (I-PRESERVE). European Journal of Heart Failure, Supplement. 7:87-87. 2008
- Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - findings from the I-PRESERVE trial. European Journal of Heart Failure, Supplement. 7:86-86. 2008
- The Canadian Cardiovascular Society (CCS) heart failure consensus conference program: shaping the future of heart failure management in Canada. European Journal of Heart Failure, Supplement. 7:17-17. 2008
- Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal. 29:1224-1240. 2008
- Puzzling practice: A strategy for working with clinical practice issues. International Journal of Nursing Practice. 14:94-100. 2008
- A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clinical Biochemistry. 41:260-265. 2008
- BNP and NT‐proBNP predict echocardiographic severity of diastolic dysfunction. EUROPEAN JOURNAL OF HEART FAILURE. 10:252-259. 2008
- Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: A systematic review. Clinical Biochemistry. 41:250-259. 2008
- Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. Clinical Biochemistry. 41:240-249. 2008
- Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: Is BNP or NT-proBNP a useful assessment tool?. Clinical Biochemistry. 41:266-276. 2008
- Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clinical Biochemistry. 41:231-239. 2008
- Exercise training in patients with heart failure: clinical outcomes, safety, and indications. Heart Failure Reviews. 13:3-11. 2008
- Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I‐PRESERVE trial. EUROPEAN JOURNAL OF HEART FAILURE. 10:149-156. 2008
- Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure. EUROPEAN JOURNAL OF HEART FAILURE. 10:125-128. 2008
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure – 2008 update: Best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Canadian Journal of Cardiology. 24:21-40. 2008
- Heart failure: Old disease, older adults, fresh perspective. Geriatrics and Aging. 11:15-21. 2008
- Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). American Heart Journal. 155:26.e1-26.e13. 2008
- The effects of exercise training on insulin resistance in patients with coronary artery disease. European Journal of Preventive Cardiology (EJPC). 14:803-808. 2007
- Origins of arterial and femoral venous acid–base responses during moderate-intensity bicycling exercise after glycogen depletion in men. Comparative Exercise Physiology. 4:123-133. 2007
- Abstract 3148: Atrial Fibrillation Is Associated With Increased Risk Of Fatal And Non-fatal Cardiovascular Events In Patients With Heart Failure And Preserved Ejection Fraction - Findings From The Irbesartan In Heart Failure With Preserved Systolic Function Trial (I-PRESERVE). Circulation. 116. 2007
- Abstract 3640: Diabetes Mellitus is Associated with Increased Risk of Fatal and Non-Fatal Cardiovascular Events in Heart Failure Patients with Preserved Ejection Fraction - Findings From the Irbesartan in Heart Failure with Preserved Systolic Function Trial. Circulation. 116. 2007
- IN REPLY TO DRS. PARASHAR AND VARMA. Journal of The American Geriatrics Society. 55:1303-1304. 2007
- Reply. Journal of the American College of Cardiology. 50:79-80. 2007
- Necessary cautions when considering digoxin in heart failure. CANADIAN MEDICAL ASSOCIATION JOURNAL. 176:644-645. 2007
- Diastolic Dysfunction in Heart Failure With Preserved Systolic Function: Need for Objective Evidence. Journal of the American College of Cardiology. 49:687-694. 2007
- Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Canadian Journal of Cardiology. 23:21-45. 2007
- Characterization of health‐related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. EUROPEAN JOURNAL OF HEART FAILURE. 9:83-91. 2007
- Effect of aerobic vs combined aerobic-strength training on 1-year, post-cardiac rehabilitation outcomes in women after a cardiac event. Journal of Rehabilitation Medicine. 39:730-735. 2007
- Heart failure and cognitive impairment: challenges and opportunities.. Clinical interventions in aging. 2:209-218. 2007
- Heart failure.. American Family Physician. 2007:0204. 2007
- ASSOCIATION BETWEEN PSYCHOTROPIC DRUG USE AND HEART FAILURE THERAPY IN ELDERLY LONG‐TERM CARE RESIDENTS. Journal of The American Geriatrics Society. 54:1973-1975. 2006
- Candesartan for the management of heart failure: more than an alternative. Expert Opinion on Pharmacotherapy. 7:1945-1956. 2006
- Plasma Matrix Metalloproteinase-9 Level Is Correlated With Left Ventricular Volumes and Ejection Fraction in Patients With Heart Failure. Journal of Cardiac Failure. 12:514-519. 2006
- Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.. Evidence report/technology assessment. 1-147. 2006
- Current and Future Uses of Candesartan in the Treatment of Heart Failure. Future Cardiology. 2:391-402. 2006
- Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. American Heart Journal. 151:1324.e11-1324.e18. 2006
- Exercise and the Heart Failure Patient: Aerobic vs Strength Training—Is There a Need for Both?. Progress in Cardiovascular Nursing. 21:146-150. 2006
- Growth hormone therapy as a treatment for heart failure. Evidence-based Cardiovascular Medicine. 10:81-84. 2006
- Heart failure.. Clinical Evidence. 118-139. 2006
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. New England Journal of Medicine. 354:1464-1476. 2006
- Initial data supporting the design of the Candesartan in Heart failure — Assessment of Reduction in Mortality and morbidity (CHARM) programme. Journal of Hypertension. 24:S9-S13. 2006
- Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology. 22:23-45. 2006
- Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure. Journal of the American Medical Association (JAMA). 294:1794-1794. 2005
- The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design. Journal of Cardiac Failure. 11:576-585. 2005
- Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both. American Journal of Cardiology. 96:698-704. 2005
- Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?. Expert Opinion on Investigational Drugs. 14:1009-1018. 2005
- Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice. EUROPEAN JOURNAL OF HEART FAILURE. 7:710-721. 2005
- Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. EUROPEAN JOURNAL OF HEART FAILURE. 7:650-656. 2005
- . Evidence-based Cardiovascular Medicine. 9:90-90. 2005
- Digoxin prescribing for heart failure in elderly residents of long-term care facilities.. Canadian Journal of Cardiology. 21:281-286. 2005
- The role of exercise training for patients with heart failure.. European Journal of Physical and Rehabilitation Medicine. 41:35-47. 2005
- ACE Inhibitors in Heart Failure. American Journal of Cardiovascular Drugs. 5:351-359. 2005
- Haemodynamic and neurohormonal effects of AT1-receptor blockers. European Heart Journal, Supplement. 6:h49-h54. 2004
- Heart failure.. Clinical Evidence. 115-143. 2004
- Metabolic Profile and Exercise Capacity Outcomes. Journal of Cardiopulmonary Rehabilitation and Prevention. 24:405-413. 2004
- Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction. Circulation. 110:2618-2626. 2004
- Differences in sustainability of exercise and health-related quality of life outcomes following home or hospital-based cardiac rehabilitation. European Journal of Preventive Cardiology (EJPC). 11:313-319. 2004
- Management of heart failure in Canadian long-term care facilities.. Canadian Journal of Cardiology. 20:963-969. 2004
- Valsartan plus captopril did not improve survival more than captopril alone after myocardial infarction. ACP journal club. 141:3-3. 2004
- Heart failure.. Clinical Evidence. 122-148. 2004
- 1033-109 Assessing the need for repeat baseline exercise tests in heart failure patients: Early experience from HF-ACTION. Journal of the American College of Cardiology. 43:A167-A167. 2004
- The impact of an outpatient heart failure clinic on hospital costs and admissions. Leadership in Health Services. 17:1-11. 2004
- The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure. Expert Opinion on Investigational Drugs. 13:245-253. 2004
- Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). The BMJ. 328:189-0. 2004
- Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both. New England Journal of Medicine. 349:1893-1906. 2003
- Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. European Heart Journal. 24:1727-1734. 2003
- Heart failure.. Clinical Evidence. 95-118. 2003
- The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.. Canadian Journal of Cardiology. 19:347-356. 2003
- Growth Hormone Therapy in Heart Failure: Where Are We Now?. Congestive Heart Failure. 9:84-90. 2003
- The Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure Patients. Congestive Heart Failure. 9:29-34. 2003
- Heart failure.. Clinical Evidence. 60-81. 2002
- A controlled trial of hospital versus home-based exercise in cardiac patients. Medicine & Science in Sports & Exercise. 34:1544-1550. 2002
- Reliability, Validity, and Responsiveness of the Six-minute Walk Test in Patients with Heart Failure.. Cardiopulmonary Physical Therapy Journal. 13:18-18. 2002
- Review: angiotensin receptor blockers do not reduce mortality or hospital admission rates in heart failure. BMJ Evidence-Based Medicine. 7:141-141. 2002
- Effects of exercise training in patients with heart failure: The Exercise Rehabilitation Trial (EXERT). American Heart Journal. 144:23-30. 2002
- Heart failure.. Clinical Evidence. 57-78. 2002
- Reliability, validity, and responsiveness of the 6-minute walk test in patients with heart failure. ACC Cardiosource Review Journal. 11:47-48. 2002
- Vimentin Exposed on Activated Platelets and Platelet Microparticles Localizes Vitronectin and Plasminogen Activator Inhibitor Complexes on Their Surface. Journal of Biological Chemistry. 277:7529-7539. 2002
- Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. Journal of the American College of Cardiology. 39:463-470. 2002
- Heart failure (Reprinted from Clin Evid, vol 5, pg 43-62, 2001). American Family Physician. 65:99-102. 2002
- Heart failure.. American Family Physician. 65:99-102. 2002
- The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.. Canadian Journal of Cardiology. 17 Suppl E:5E-25E. 2001
- Acute cardiovascular responses to leg-press resistance exercise in heart transplant recipients. International Journal of Cardiology. 81:61-74. 2001
- Acute Precipitants of Congestive Heart Failure Exacerbations. JAMA Internal Medicine. 161:2337-2337. 2001
- Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. American Heart Journal. 142:698-703. 2001
- Angiotensin receptor blockers for heart failure. Clinical Respiratory Journal. CD003040. 2001
- Changes in Exercise Capacity and Lipids after Clinic Versus Home-based Aerobic Training in Coronary Artery Bypass Graft Surgery Patients. Journal of Cardiopulmonary Rehabilitation and Prevention. 21:31-36. 2001
- 2000 revision of the Canadian Cardiovascular Society 1997 Consensus Conference on the Evaluation and Management of Chronic Ischemic Heart Disease.. Canadian Journal of Cardiology. 16:1513-1536. 2000
- Functional capacity in patients with congestive heart failure. Journal of Cardiac Failure. 6:214-219. 2000
- THE EFFECT OF INSTITUTION-BASED (IBE) VS. MONITORED HOME-BASED EXERCISE (HBE) ON PHYSICAL AND PSYCHOLOGICAL OUTCOMES IN LOW-RISK CORONARY ARTERY BYPASS GRAFT SURGERY (CABG) PATIENTS: RESULTS OF A RANDOMIZED CONTROL TRIAL. Journal of Cardiopulmonary Rehabilitation and Prevention. 20:305-305. 2000
- Effect of a Preoperative Intervention on Preoperative and Postoperative Outcomes in Low-Risk Patients Awaiting Elective Coronary Artery Bypass Graft Surgery. ACP journal club. 133:253-253. 2000
- Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. European Heart Journal. 21:1368-1375. 2000
- Controlled- and extended-release metoprolol reduced mortality in congestive heart failure. ACP journal club. 133:3-3. 2000
- Interobserver reliability and validity of the New York Heart Association Functional Classification (NYHA‐FC) in heart failure patients. EUROPEAN JOURNAL OF HEART FAILURE. 2:73-74. 2000
- A multidisciplinary, home based intervention reduced deaths and readmissions in patients with chronic congestive heart failure. BMJ Evidence-Based Medicine. 5:84-84. 2000
- A multidisciplinary, home-based intervention reduced deaths and readmissions in patients with chronic congestive heart failure. ACP journal club. 132:88-88. 2000
- Regular review: Drug treatment in heart failure. The BMJ. 320:1188-1192. 2000
- Effects of Metoprolol CR in Patients With Ischemic and Dilated Cardiomyopathy. Circulation. 101:378-384. 2000
- Controlled- and extended-release metoprolol reduced mortality in congestive heart failure. ACP journal club. 132:3-3. 2000
- Controlled- and extended-release metoprolol reduced mortality in congestive heart failure. ACP journal club. 132:2-2. 2000
- Exercise training for patients with chronic heart failure reduced mortality and cardiac events and improved quality of life. Western Journal of Medicine. 172:28-28. 2000
- Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Prevention and Management of Congestive Heart Failure. 5:286-287. 1999
- Validity of predicting mean arterial blood pressure during exercise. Medicine & Science in Sports & Exercise. 31:1876-1876. 1999
- Vigorous exercise combined with a cognitive-behavioral smoking cessation program was effective in smoking cessation. Evidence-based Cardiovascular Medicine. 3:106-106. 1999
- Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure. Circulation. 100:1056-1064. 1999
- Bisoprolol reduced all-cause mortality, cardiovascular mortality, and hospitalization in CHF. ACP journal club. 131:5-5. 1999
- Long-term moderate exercise training improved functional capacity and quality of life in patients with stable chronic heart failure. JBI evidence implementation. 3:39-39. 1999
- Long-term moderate exercise training improved functional capacity and quality of life in patients with stable chronic heart failure. Evidence-based Cardiovascular Medicine. 3:39-39. 1999
- Evidence based cardiology: Prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction. The BMJ. 318:1400-1402. 1999
- Exercise training in heart failure: How?. Heart Failure Reviews. 3:263-271. 1999
- The role of digitalis in the treatment of heart failure. Coronary Artery Disease. 10:353-360. 1999
- Combination of diet and exercise effective in reducing LDL-cholesterol. Evidence-based Cardiovascular Medicine. 2:95-95. 1998
- Community management of heart failure.. Canadian Family Physician. 44:2689-2698. 1998
- EXERCISE TRAINING FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY (CABG); PROGRAM OUTCOMES.. Journal of Cardiopulmonary Rehabilitation and Prevention. 18:384-384. 1998
- The effect of beta-blockade on plasma potassium concentrations and muscle excitability following static exercise. Pflugers Archiv European Journal of Physiology. 436:449-456. 1998
- Muscle performance and enzymatic adaptations to sprint interval training. Journal of applied physiology. 84:2138-2142. 1998
- Clinical Workload Decreases the Level of Aerobic Fitness in Housestaff Physicians. Journal of Cardiopulmonary Rehabilitation and Prevention. 18:216-220. 1998
- Randomized controlled trial of exercise training in patients with congestive heart failure (EXERT). Journal of the American College of Cardiology. 31:508-509. 1998
- Increased insulin and glucose levels in heart failure (HF). Journal of the American College of Cardiology. 31:249-249. 1998
- Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.. Canadian Journal of Cardiology. 13:1166-1174. 1997
- LV internal dimensions predicted an increased risk of CHF in patients free of MI. Evidence-based Cardiovascular Medicine. 1:95-95. 1997
- Comparative Effects of Losartan and Enalapril on Exercise Capacity and Clinical Status in Patients With Heart Failure fn1fn1This study was supported by a grant from Merck Research Laboratories, West Point, Pennsylvania.. Journal of the American College of Cardiology. 30:983-991. 1997
- Prevalence of impaired glucose tolerance in coronary artery disease (cad) patients. Journal of Cardiopulmonary Rehabilitation and Prevention. 17:353-353. 1997
- 91 Design of the randomized evaluation of strategies for left ventricular dysfunction (resolvd) pilot study: A trial of combination neurohormonal blockade in patients with congestive heart failure. Contemporary Clinical Trials. 18:S98-S98. 1997
- Enhanced pulmonary and active skeletal muscle gas exchange during intense exercise after sprint training in men. Journal of Physiology. 501:703-716. 1997
- Sprint training enhances ionic regulation during intense exercise in men. Journal of Physiology. 501:687-702. 1997
- LARGE INCREASES IN SKELETAL MUSCLE NA+,K+-ATPASE CONCENTRATION AFTER HIGH INTENSITY SPRINT TRAINING 1318. Medicine & Science in Sports & Exercise. 29:230-230. 1997
- Effect of progressive incremental exercise and β-adrenergic blockade on erythrocyte ion concentrations. Canadian Journal of Physiology and Pharmacology. 75:19-25. 1997
- The rationale for exercise training patients with congestive heart failure. Prevention and Management of Congestive Heart Failure. 3:26-34. 1997
- CLINICAL WORKLOAD & FITNESS. Journal of Cardiopulmonary Rehabilitation and Prevention. 16:334-334. 1996
- Aerobic Exercise and Normotensive Adults. Clinical Journal of Sport Medicine. 6:213-213. 1996
- MUSCLE ENZYMATIC ADAPTATIONS TO SPRINT INTERVAL TRAINING 126. Medicine & Science in Sports & Exercise. 28:21-21. 1996
- The relationship between plasma potassium, muscle membrane excitability and force following quadriceps fatigue. Pflugers Archiv European Journal of Physiology. 432:43-49. 1996
- The role of resistance training in patients with cardiac disease. European Journal of Preventive Cardiology (EJPC). 3:160-166. 1996
- Circulatory Responses to Weight Lifting, Walking, and Stair Climbing in Older Males. Journal of The American Geriatrics Society. 44:121-125. 1996
- Comparison of hemodynamic responses to cycling and resistance exercise in congestive heart failure secondary to ischemic cardiomyopathy. American Journal of Cardiology. 76:977-979. 1995
- Collaborative cardiovascular clinical trials in Canada. The Canadian Cardiovascular Collaboration.. Canadian Journal of Cardiology. 11:649-657. 1995
- Right ventricular diastolic collapse without hemodynamic compromise in a patient with large, bilateral pleural effusions. Journal of the American Society of Echocardiography. 8:551-553. 1995
- P47 Randomized controlled trial of aerobic plus resistance exercise training in patients with congestive heart failure. Contemporary Clinical Trials. 16:99S-99S. 1995
- Effects of exercise training in patients with congestive heart failure: A critical review. Journal of the American College of Cardiology. 25:789-796. 1995
- K+ and Lac- distribution in humans during and after high-intensity exercise: role in muscle fatigue attenuation?. Journal of applied physiology. 78:765-777. 1995
- Effect of selective and nonselective beta-blockade on skeletal muscle excitability and fatiguability. Journal of applied physiology. 76:2461-2466. 1994
- PLASMA-VOLUME AND ION REGULATION DURING EXERCISE AFTER LOW-CARBOHYDRATE AND HIGH-CARBOHYDRATE DIETS. American Journal of Physiology. 266:R1896-R1906. 1994
- Plasma volume and ion regulation during exercise after low- and high-carbohydrate diets. American Journal of Physiology. 266:R1896-R1906. 1994
- Role of Angiotensin Converting Enzyme Inhibitors in Patients with Left Ventricular Dysfunction and Congestive Heart Failure. European Heart Journal. 15:9-13. 1994
- 910 ESTIMATED MYOCARDIAL OXYGEN SUPPLY TO DEMAND RATIO DURING BILATERAL ARM RESISTANCE EXERCISES AND ARM ERGOMETRY. Medicine & Science in Sports & Exercise. 26:S162-S162. 1994
- Effect of Training on the Blood Pressure Response to Weight Lifting. Applied Physiology, Nutrition and Metabolism. 19:60-74. 1994
- Substrate Utilization during Heavy Exercise after Different Diets. Clinical Science. 87:55-55. 1994
- Left ventricular response in healthy young men during heavy-intensity weight-lifting exercise. Journal of applied physiology. 75:2703-2710. 1993
- PYRUVATE-DEHYDROGENASE ACTIVITY AND ACETYL GROUP ACCUMULATION DURING EXERCISE AFTER DIFFERENT DIETS. American Journal of Physiology. 265:E752-E760. 1993
- Pyruvate dehydrogenase activity and acetyl group accumulation during exercise after different diets. American Journal of Physiology. 265:E752-E760. 1993
- Comparison of blood pressure response to isokinetic and weight-lifting exercise. European Journal of Applied Physiology. 67:115-120. 1993
- Weight-training-induced attenuation of the circulatory response of older males to weight lifting. Journal of applied physiology. 74:1056-1060. 1993
- The effects of variations in the anti-G straining maneuver on blood pressure at +Gz acceleration.. Aerospace Medicine and Human Performance. 64:126-131. 1993
- Erythrocyte ion regulation across inactive muscle during leg exercise. Canadian Journal of Physiology and Pharmacology. 70:1625-1633. 1992
- Factors affecting blood pressure during heavy weight lifting and static contractions. Journal of applied physiology. 73:1590-1597. 1992
- DOES ??-BLOCKADE IMPAIR THE EXCITABILITY OF SKELETAL MUSCLE DURING EXERCISE?. Medicine & Science in Sports & Exercise. 24:S116-S116. 1992
- Usefulness of Weightlifting Training in Improving Strength and Maximal Power Output in Coronary Artery Disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 12:131-131. 1992
- Usefulness of Weightlifting Training in Improving Strength and Maximal Power Output in Coronary Artery Disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 12:131-131. 1992
- BLOOD ION REGULATION DURING REPEATED MAXIMAL EXERCISE AND RECOVERY IN HUMANS. American Journal of Physiology. 262:R126-R136. 1992
- Blood ion regulation during repeated maximal exercise and recovery in humans. American Journal of Physiology. 262:R126-R136. 1992
- Effects on Quality of Life With Comprehensive Rehabilitation After Acute Myocardial Infarction. Journal of Cardiopulmonary Rehabilitation and Prevention. 12:63-63. 1992
- Contribution of erythrocytes to the control of the electrolyte changes of exercise. Canadian Journal of Physiology and Pharmacology. 69:984-993. 1991
- Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. American Journal of Cardiology. 67:1084-1089. 1991
- Usefulness of weightlifting training in improving strength and maximal power output in coronary artery disease. American Journal of Cardiology. 67:939-945. 1991
- Effects of steady state exercise on the power spectrum of heart rate variability. Medicine & Science in Sports & Exercise. 23:428???434-428???434. 1991
- Factors contributing to increased muscle fatigue with β-blockers. Canadian Journal of Physiology and Pharmacology. 69:254-261. 1991
- Weightlifting Training in Cardiac Patients. Sports Medicine. 10:355-364. 1990
- Comparison of direct and indirect measures of systemic arterial pressure during weightlifting in coronary artery disease. American Journal of Cardiology. 66:1065-1069. 1990
- ROLE OF NONWORKING MUSCLE ON BLOOD METABOLITES AND IONS WITH INTENSE INTERMITTENT EXERCISE. American Journal of Physiology. 258:R1486-R1494. 1990
- Role of nonworking muscle on blood metabolites and ions with intense intermittent exercise. American Journal of Physiology. 258:R1486-R1494. 1990
- 150 ERYTHROCYTE (RBC) POTASSIUM ([K+]) AND LACTATE ([La-]) CONCENTRATION DURING INCREMENTAL EXERCISE. Medicine & Science in Sports & Exercise. 22:S25-S25. 1990
- 26 INDIRECT VS DIRECT MEASURES OF ARTERIAL PRESSURE DURING WEIGHTLIFTING IN CARDIAC PATIENTS. Medicine & Science in Sports & Exercise. 22:S5-S5. 1990
- RENAL RESPONSES TO EXERCISE-INDUCED LACTIC-ACIDOSIS. American Journal of Physiology. 257:R102-R108. 1989
- Renal responses to exercise-induced lactic acidosis. American Journal of Physiology. 257:R102-R108. 1989
- Cardiopulmonary Exercise Testing. Clinics in Chest Medicine. 10:277-291. 1989
- EFFECTS OF THE VALSALVA MANEUVER, JOINT ANGLE, MUSCLE SIZE & STRENGTH ON THE BLOOD PRESSURE RESPONSE TO WEIGHTLIFTING. Medicine & Science in Sports & Exercise. 21:S2-S2. 1989
- WEIGHT-TRAINING INDUCED ATTENUATION OF THE PRESSOR RESPONSE TO WEIGHTLIFTING IN OLDER MALES.. Medicine & Science in Sports & Exercise. 21:S2-S2. 1989
- Estimation of Cardiac Output by C0(2) Rebreathing during Incremental Exercise in Patients with Coronary Artery Disease. American Journal of Noninvasive Cardiology. 3:147-153. 1989
- Muscle glycogenolysis and H+ concentration during maximal intermittent cycling. Journal of applied physiology. 66:8-13. 1989
- Direct Measurements of Arterial Blood Pressure During Formal Weightlifting in Cardiac Patients. Journal of Cardiopulmonary Rehabilitation and Prevention. 8:213-225. 1988
- Measurement of Cardiac Output by CO2 Rebreathing in Unsteady State Exercise. Chest. 92:777-782. 1987
- 202. Medicine & Science in Sports & Exercise. 19:S34-S34. 1987
- 498. Medicine & Science in Sports & Exercise. 19:S83-S83. 1987
- 511. Medicine & Science in Sports & Exercise. 19:S86-S86. 1987
- 513. Medicine & Science in Sports & Exercise. 19:S86-S86. 1987
- 559. Medicine & Science in Sports & Exercise. 19:S94-S94. 1987
- Heart rate variability power spectrogram as a potential noninvasive signature of cardiac regulatory system response, mechanisms, and disorders. Heart and Vessels. 3:33-41. 1987
- EFFECTS OF MAXIMUM ISOKINETIC CYCLING EXERCISE (MICE) ON BLOOD METABOLITES AND ACID-BASE STATE IN MAN. Medicine & Science in Sports & Exercise. 18:S76-S76. 1986
- Late Collateralization of Coronary Arteries From a Previously Non-Functioning Internal Mammary Artery Implant: A Case Summary. Vascular and Endovascular Surgery. 19:252-257. 1985
- EFFECTS OF THE VALSALVA MANEUVER, JOINT ANGLE, MUSCLE SIZE & STRENGTH ON THE BLOOD PRESSURE RESPONSE TO WEIGHTLIFTING. Medicine & Science in Sports & Exercise. 21:S2-S2. 1980
- WEIGHT-TRAINING INDUCED ATTENUATION OF THE PRESSOR RESPONSE TO WEIGHTLIFTING IN OLDER MALES.. Medicine & Science in Sports & Exercise. 21:S2-S2. 1980
- Influence of alternate sources of blood flow on the reactive hyperemia response in aorta-coronary saphenous vein bypass grafts in man. Journal of Thoracic and Cardiovascular Surgery. 78:62-67. 1979
- Abstracts from the 32nd Annual Scientific Meeting of the Canadian Geriatrics Society Quebec City, April 2012. Canadian Geriatrics Journal. 15:37-66.